Recent Finacing
Recent Raise
NeuWave develops and commercializes microwave and energy-based minimally invasive soft-tissue ablation systems (e.g., Certus 140) for treating primary and metastatic lung, liver, and kidney lesions, used across U.S. hospitals.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors